Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,122,599 | 599,674 | 514,179 | 372,776 | 283,703 |
| Cost of Goods | 4,384 | 1,820 | N/A | N/A | N/A |
| Gross Profit | 1,118,215 | 597,854 | 514,179 | 372,776 | 283,703 |
| Operating Expenses | 752,716 | 660,046 | 483,132 | 392,936 | 359,465 |
| Operating Income | 365,883 | -61,372 | 31,047 | -20,160 | -75,762 |
| Interest Expense | 12,440 | 44,789 | 44,752 | 38,795 | 36,732 |
| Other Income | -14,677 | 30,005 | -3,058 | 1,489 | 24,588 |
| Pre-tax Income | 338,766 | -76,156 | -16,763 | -57,466 | -87,906 |
| Income Tax | 51,507 | -291,141 | -5,980 | 2,934 | 372 |
| Net Income Continuous | 287,259 | 214,985 | -10,783 | -60,400 | -88,278 |
| Minority Interests | 9,116 | -58,756 | N/A | N/A | N/A |
| Net Income | $278,143 | $273,741 | $-10,783 | $-60,400 | $-88,278 |
| EPS Basic Total Ops | 2.00 | 2.09 | 0.15 | -0.50 | -0.74 |
| EPS Basic Continuous Ops | 2.05 | 1.62 | -0.09 | -0.50 | -0.74 |
| EPS Diluted Total Ops | 1.90 | 2.07 | 0.15 | -0.50 | -0.74 |
| EPS Diluted Continuous Ops | 1.88 | 1.60 | -0.09 | -0.50 | -0.74 |
| EPS Diluted Before Non-Recurring Items | 2.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $377,337 | $-14,684 | $82,343 | $27,494 | $-27,839 |